These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27287011)

  • 1. LC-MS analysis combined with principal component analysis and soft independent modelling by class analogy for a better detection of changes in N-glycosylation profiles of therapeutic glycoproteins.
    Planinc A; Dejaegher B; Heyden YV; Viaene J; Van Praet S; Rappez F; Van Antwerpen P; Delporte C
    Anal Bioanal Chem; 2017 Jan; 409(2):477-485. PubMed ID: 27287011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture.
    Segu ZM; Hussein A; Novotny MV; Mechref Y
    J Proteome Res; 2010 Jul; 9(7):3598-607. PubMed ID: 20405899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Preparation of Released N-Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection.
    Lauber MA; Yu YQ; Brousmiche DW; Hua Z; Koza SM; Magnelli P; Guthrie E; Taron CH; Fountain KJ
    Anal Chem; 2015; 87(10):5401-9. PubMed ID: 25927596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast and efficient online release of N-glycans from glycoproteins facilitating liquid chromatography-tandem mass spectrometry glycomic profiling.
    Jmeian Y; Hammad LA; Mechref Y
    Anal Chem; 2012 Oct; 84(20):8790-6. PubMed ID: 22978794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins.
    Shang TQ; Saati A; Toler KN; Mo J; Li H; Matlosz T; Lin X; Schenk J; Ng CK; Duffy T; Porter TJ; Rouse JC
    J Pharm Sci; 2014 Jul; 103(7):1967-1978. PubMed ID: 24840237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-N-glycosidase F or A treatment and procainamide-labeling for identification and quantification of N-glycans in two types of mammalian glycoproteins using UPLC and LC-MS/MS.
    Kim A; Kim J; Park CS; Jin M; Kang M; Moon C; Kim M; Kim J; Yang S; Jang L; Jang JY; Kim HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1214():123538. PubMed ID: 36493594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-glycan Profiling of Glycoproteins by Hydrophilic Interaction Liquid Chromatography with Fluorescence and Mass Spectrometric Detection.
    Kayili HM; Salih B
    J Vis Exp; 2021 Sep; (175):. PubMed ID: 34633372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophilic interaction liquid chromatography-mass spectrometry as a new tool for the characterization of intact semi-synthetic glycoproteins.
    Tengattini S; Domínguez-Vega E; Temporini C; Bavaro T; Rinaldi F; Piubelli L; Pollegioni L; Massolini G; Somsen GW
    Anal Chim Acta; 2017 Aug; 981():94-105. PubMed ID: 28693734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N- and O-glycosylation analysis of etanercept using liquid chromatography and quadrupole time-of-flight mass spectrometry equipped with electron-transfer dissociation functionality.
    Houel S; Hilliard M; Yu YQ; McLoughlin N; Martin SM; Rudd PM; Williams JP; Chen W
    Anal Chem; 2014 Jan; 86(1):576-84. PubMed ID: 24308717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of N-glycosylated protein and N-glycans in human plasma by hydrophilic enrichment strategy].
    Ma C; Pan Y; Zhang Q; Wang J; Qian X; Ying W
    Se Pu; 2013 Nov; 31(11):1057-63. PubMed ID: 24558840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Traditional 2-AB Fluorescence LC-MS/MS and Automated LC-MS for the Comparative Glycan Analysis of Monoclonal Antibodies.
    Schiel JE; Rogstad SM; Boyne MT
    J Pharm Sci; 2015 Aug; 104(8):2464-72. PubMed ID: 26053232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity.
    Parker BL; Thaysen-Andersen M; Solis N; Scott NE; Larsen MR; Graham ME; Packer NH; Cordwell SJ
    J Proteome Res; 2013 Dec; 12(12):5791-800. PubMed ID: 24090084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.
    Liu T; Qian WJ; Gritsenko MA; Camp DG; Monroe ME; Moore RJ; Smith RD
    J Proteome Res; 2005; 4(6):2070-80. PubMed ID: 16335952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates of the current strategies of labeling for N-glycan analysis.
    Helali Y; Delporte C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124068. PubMed ID: 38484674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batch-to-batch N-glycosylation study of infliximab, trastuzumab and bevacizumab, and stability study of bevacizumab.
    Planinc A; Dejaegher B; Vander Heyden Y; Viaene J; Van Praet S; Rappez F; Van Antwerpen P; Delporte C
    Eur J Hosp Pharm; 2017 Sep; 24(5):286-292. PubMed ID: 31156959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HILIC analysis of fluorescence-labeled N-glycans from recombinant biopharmaceuticals.
    Melmer M; Stangler T; Schiefermeier M; Brunner W; Toll H; Rupprechter A; Lindner W; Premstaller A
    Anal Bioanal Chem; 2010 Sep; 398(2):905-14. PubMed ID: 20640408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins.
    Halim A; Rüetschi U; Larson G; Nilsson J
    J Proteome Res; 2013 Feb; 12(2):573-84. PubMed ID: 23234360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific Analysis of N-Linked Glycosylation Heterogeneity from Royal Jelly Glycoproteins.
    Lin N; Li J; Shao R; Zhang H
    J Agric Food Chem; 2019 Aug; 67(33):9411-9422. PubMed ID: 31393126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.